CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net loss	$ (15,085)	$ (16,941)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	128	243
Stock-based compensation expense	3,535	2,089
Revaluation of contingent consideration	300	2,800
Changes in operating assets and liabilities:
Accounts receivable	68	(75)
Prepaid expenses and other assets	8,208	2,044
Accounts payable	1,664	1,932
Accrued expenses and other liabilities	(11,042)	(12,907)
Deferred income	(833)
Net cash used in operating activities	(13,057)	(20,815)
Cash flows from investing activities:
Purchases of property and equipment	(43)	(135)
Purchases of marketable securities	(9,996)
Proceeds from sales and maturities of marketable securities	29,991	16,968
Payment of deferred transaction consideration for in-licensed assets	(833)
Net cash provided by investing activities	19,119	16,833
Cash flows from financing activities:
Payments of employee withholding taxes related to restricted stock unit award vesting	(275)	(55)
Net cash used in financing activities	(275)	(55)
Net increase (decrease) in cash and cash equivalents	5,787	(4,037)
Cash and cash equivalents at beginning of period	24,570	39,878
Cash and cash equivalents at end of period	$ 30,357	$ 35,841